Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Clinical trial NCT04684459 · RECRUITING

Trial details

NCT number: NCT04684459
Sponsor: Sichuan University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Peritoneal Carcinoma Metastatic Pleural Effusion, Malignant HER2 Positive Malignancies

Start date: 2021-03-12
Primary completion: 2025-12-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.